The earnings call presented a generally positive outlook with significant achievements in revenue growth, cash flow improvement, and successful hospital negotiations. However, there are challenges related to overall revenue decline and potential impacts from legislative changes. Despite these challenges, the company's strong performance and strategic positioning contribute to a positive overall sentiment.

Company Guidance -

Q3 2025

During the Q2 2025 earnings call, Pediatrix Medical Group provided updated guidance, highlighting a strong financial performance that exceeded expectations, with adjusted EBITDA reaching over $73 million. This success was attributed to a same-unit revenue growth of over 6%, driven by a 6% increase in NICU days and favorable reimbursement factors. The company has raised and narrowed its full-year adjusted EBITDA outlook to a range of $245 million to $255 million. Despite a 7% decline in consolidated revenue due to portfolio restructuring, same-unit growth remained robust. Cash flow generation was also strong, with $138 million in operating cash flow, leading to a healthy cash balance of $225 million and a net debt of just over $380 million. The company anticipates ending 2025 with a cash balance between $350 million and $400 million, maintaining a net leverage ratio of just above 1.5x.

Exceeded Expectations in Q2 2025

Adjusted EBITDA of over $73 million, driven by same-unit revenue growth of over 6% and NICU days up 6%.

Increased Full Year Adjusted EBITDA Guidance

Raised and narrowed full year adjusted EBITDA range to $245 million to $255 million.

Strong Cash Flow and Balance Sheet

Generated $138 million in operating cash flow with a cash balance of $225 million and net debt of just over $380 million.

Improved Revenue Cycle Management

Accounts receivable DSO decreased by over 3 days year-over-year, reflecting improved cash collections.

Hospital Relationships and Admin Fee Growth

Successful negotiations led to hospital admin fees contributing about 1/3 of the pricing growth.

Pediatrix Medical Group (MD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

MD Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 30, 2025	2025 (Q3)	0.46 / -	0.44	―	―	―
Jun 30, 2025	2025 (Q2)	0.42 / 0.53	0.34	55.88% (+0.19)	―	―
May 06, 2025	2025 (Q1)	0.24 / 0.33	0.2	65.00% (+0.13)	―
Feb 20, 2025	2024 (Q4)	0.37 / 0.51	0.32	59.38% (+0.19)	―
Nov 01, 2024	2024 (Q3)	0.37 / 0.44	0.32	37.50% (+0.12)	―
Aug 06, 2024	2024 (Q2)	0.31 / 0.34	0.39	-12.82% (-0.05)	―
May 07, 2024	2024 (Q1)	0.18 / 0.20	0.23	-13.04% (-0.03)	―
Feb 20, 2024	2023 (Q4)	0.33 / 0.32	0.47	-31.91% (-0.15)	―
Nov 02, 2023	2023 (Q3)	0.43 / 0.32	0.4	-20.00% (-0.08)	―
Aug 03, 2023	2023 (Q2)	0.40 / 0.39	0.47	-17.02% (-0.08)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

MD Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jun 30, 2025	$14.03	$14.35	+2.28%
May 06, 2025	$12.95	$14.48	+11.81%
Feb 20, 2025	$14.11	$17.23	+22.11%
Nov 01, 2024	$12.32	$15.21	+23.46%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Pediatrix Medical Group (MD) report earnings?

Pediatrix Medical Group (MD) is schdueled to report earning on Oct 30, 2025, Before Open (Confirmed).

What is Pediatrix Medical Group (MD) earnings time?

Pediatrix Medical Group (MD) earnings time is at Oct 30, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is MD EPS forecast?

MD EPS forecast for the fiscal quarter 2025 (Q3) is 0.46.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing